Cargando…
Early gene expression changes with rush immunotherapy
BACKGROUND: To examine whether whole genome expression profiling could reveal changes in mRNA expression of peripheral blood mononuclear cells (PBMC) from allergic patients undergoing rush immunotherapy (RIT) that might be manifest within the first few months of treatment. METHODS: For this study, P...
Autores principales: | Davis, Laurie S, Bhutani, Sumit, Barnett, Sherry Ridz, Khan, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195724/ https://www.ncbi.nlm.nih.gov/pubmed/21961521 http://dx.doi.org/10.1186/1476-7961-9-12 |
Ejemplares similares
-
Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)
por: Stock, Richard, et al.
Publicado: (2020) -
Time-dependent cytokines changes in ultra-rush wasp venom immunotherapy
por: Urbańska, W., et al.
Publicado: (2023) -
Clinical Utility of Rush Venom Immunotherapy: Current Status
por: Gruzelle, Vianney, et al.
Publicado: (2020) -
Rush Medical College
por: Davis, N. S.
Publicado: (1853) -
Rush immunotherapy in two cats with atopic skin syndrome
por: Jones, Selene, et al.
Publicado: (2021)